Oura, K.; Morishita, A.; Nakahara, M.; Tadokoro, T.; Fujita, K.; Tani, J.; Masaki, T.; Kobara, H.
Chronic Liver Disease Associated Cholangiocarcinoma: Genomic Insights and Precision Therapeutic Strategies. Cancers 2025, 17, 3052.
https://doi.org/10.3390/cancers17183052
AMA Style
Oura K, Morishita A, Nakahara M, Tadokoro T, Fujita K, Tani J, Masaki T, Kobara H.
Chronic Liver Disease Associated Cholangiocarcinoma: Genomic Insights and Precision Therapeutic Strategies. Cancers. 2025; 17(18):3052.
https://doi.org/10.3390/cancers17183052
Chicago/Turabian Style
Oura, Kyoko, Asahiro Morishita, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Tsutomu Masaki, and Hideki Kobara.
2025. "Chronic Liver Disease Associated Cholangiocarcinoma: Genomic Insights and Precision Therapeutic Strategies" Cancers 17, no. 18: 3052.
https://doi.org/10.3390/cancers17183052
APA Style
Oura, K., Morishita, A., Nakahara, M., Tadokoro, T., Fujita, K., Tani, J., Masaki, T., & Kobara, H.
(2025). Chronic Liver Disease Associated Cholangiocarcinoma: Genomic Insights and Precision Therapeutic Strategies. Cancers, 17(18), 3052.
https://doi.org/10.3390/cancers17183052
